ArticlePloS one2015

Low Dose Infliximab for Prevention of Postoperative Recurrence of Crohn's Disease: Long Term Follow-Up and Impact of Infliximab Trough Levels and Antibodies to Infliximab.

Dario Sorrentino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.